HK1137807A1 - Diagnosis of infections or inflammatory diseases of the airways and lungs associated with heart failure - Google Patents
Diagnosis of infections or inflammatory diseases of the airways and lungs associated with heart failureInfo
- Publication number
- HK1137807A1 HK1137807A1 HK10101319.0A HK10101319A HK1137807A1 HK 1137807 A1 HK1137807 A1 HK 1137807A1 HK 10101319 A HK10101319 A HK 10101319A HK 1137807 A1 HK1137807 A1 HK 1137807A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- airways
- infections
- diagnosis
- heart failure
- inflammatory diseases
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/585—Calcitonins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/12—Pulmonary diseases
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/325—Heart failure or cardiac arrest, e.g. cardiomyopathy, congestive heart failure
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Endocrinology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102006046996A DE102006046996A1 (de) | 2006-10-01 | 2006-10-01 | Diagnose von Infektionen oder Entzündungserkrankungen der Atemwege und Lunge assoziiert mit Herzinsuffizienz |
| PCT/DE2007/001759 WO2008040328A2 (fr) | 2006-10-01 | 2007-10-01 | Diagnostic d'infections ou de maladies inflammatoires des voies respiratoires et des poumons associés à l'insuffisance cardiaque |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1137807A1 true HK1137807A1 (en) | 2010-08-06 |
Family
ID=39134486
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK10101319.0A HK1137807A1 (en) | 2006-10-01 | 2010-02-05 | Diagnosis of infections or inflammatory diseases of the airways and lungs associated with heart failure |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US8465941B2 (fr) |
| EP (1) | EP2084545B1 (fr) |
| JP (2) | JP5058263B2 (fr) |
| CN (1) | CN101553733B (fr) |
| DE (1) | DE102006046996A1 (fr) |
| ES (1) | ES2455168T3 (fr) |
| HK (1) | HK1137807A1 (fr) |
| WO (1) | WO2008040328A2 (fr) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1882945A1 (fr) * | 2006-07-28 | 2008-01-30 | F.Hoffmann-La Roche Ag | Procedes et moyens permettant de differenciation entre des causes cardiaques et pulmonaires de dyspnée aiguë |
| DE102006060112A1 (de) * | 2006-12-20 | 2008-06-26 | Brahms Aktiengesellschaft | Diagnose und Risikostratifizierung mittels dem neuen Marker CT-proADM |
| DE102007009751A1 (de) | 2007-02-28 | 2008-09-04 | B.R.A.H.M.S Aktiengesellschaft | Verfahren zur selektiven Bestimmung von Procalcitonin 1-116 für diagnostische Zwecke sowie Antikörper und Kits zur Durchführung eines solchen Verfahrens |
| DE102007021443A1 (de) * | 2007-05-08 | 2008-11-13 | Brahms Aktiengesellschaft | Diagnose und Risikostratifizierung mittels NT-proET-1 |
| ATE533061T1 (de) | 2007-08-03 | 2011-11-15 | Brahms Gmbh | Verfahren zur diagnose bakterieller infektionen |
| EP2141499A1 (fr) * | 2008-07-02 | 2010-01-06 | Apoptec AG | Diagnostic de MPOC |
| EP2318844A1 (fr) * | 2008-07-14 | 2011-05-11 | Roche Diagnostics GmbH | Panneau multimarqueur pour diagnostiquer, surveiller et sélectionner le traitement destiné à des patients souffrant d'insuffisance cardiaque |
| CN105334330A (zh) | 2009-04-14 | 2016-02-17 | B.R.A.H.M.S有限公司 | 通过测定降钙素原水平对在原发性非感染性疾病患者中的抗生素治疗进行风险评估 |
| JP5731489B2 (ja) * | 2009-06-05 | 2015-06-10 | ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング | 呼吸困難を起こした患者における細菌感染の検出 |
| DK2470910T3 (en) | 2009-08-28 | 2017-04-03 | Brahms Gmbh | Procalcitonin for the prognosis of side effects |
| RU2618437C2 (ru) * | 2010-11-01 | 2017-05-03 | Б.Р.А.Х.М.С Гмбх | Оценка прогноза и риска пациентов с неспецифическими жалобами |
| EP2637023A1 (fr) * | 2012-03-08 | 2013-09-11 | B.R.A.H.M.S GmbH | Prédiction de résultats chez les patients atteints d'une maladie pulmonaire obstructive chronique |
| RU2672561C2 (ru) * | 2012-04-12 | 2018-11-16 | Б.Р.А.Х.М.С Гмбх | Прогнозирование нежелательных явлений у пациентов с предполагаемым диагнозом хронической сердечной недостаточности |
| JP2015089364A (ja) * | 2013-11-07 | 2015-05-11 | 有限会社ジェノテックス | 体細胞多重変異によるがん診断方法、がん医薬開発方法及びがん診断装置 |
| US11143659B2 (en) | 2015-01-27 | 2021-10-12 | Arterez, Inc. | Biomarkers of vascular disease |
| EP3438668A1 (fr) * | 2017-08-04 | 2019-02-06 | B.R.A.H.M.S GmbH | Diagnostic et stratification des risques d'infections fongiques |
| US11446009B2 (en) | 2018-12-11 | 2022-09-20 | Eko.Ai Pte. Ltd. | Clinical workflow to diagnose heart disease based on cardiac biomarker measurements and AI recognition of 2D and doppler modality echocardiogram images |
| US12001939B2 (en) | 2018-12-11 | 2024-06-04 | Eko.Ai Pte. Ltd. | Artificial intelligence (AI)-based guidance for an ultrasound device to improve capture of echo image views |
| US11931207B2 (en) | 2018-12-11 | 2024-03-19 | Eko.Ai Pte. Ltd. | Artificial intelligence (AI) recognition of echocardiogram images to enhance a mobile ultrasound device |
| EP4133281A1 (fr) | 2020-04-09 | 2023-02-15 | B.R.A.H.M.S GmbH | Biomarqueurs pour le diagnostic d'infections des voies respiratoires |
| US11287396B2 (en) | 2020-06-05 | 2022-03-29 | Princeton Biochemicals, Inc. | Method and system for simultaneous determination of multiple measurable biomarkers during the development of a communicable disease |
| JPWO2022176287A1 (fr) * | 2021-02-18 | 2022-08-25 | ||
| EP4357778A1 (fr) | 2022-10-20 | 2024-04-24 | Heraeus Medical GmbH | Traitement d'infections microbiennes diagnostiquées à l'aide du d-lactate de biomarqueur |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4227454C1 (de) | 1992-08-19 | 1994-02-03 | Henning Berlin Gmbh | Verfahren zur Früherkennung, zur Erkennung des Schweregrads sowie zur therapiebegleitenden Verlaufsbeurteilung einer Sepsis sowie Mittel zur Durchführung des Verfahrens |
| DE19600875C1 (de) * | 1996-01-12 | 1997-06-26 | Brahms Diagnostica Gmbh | Diagnostisches Verfahren zur Bestimmung der Ätiologie entzündlicher Prozesse |
| DE19847690A1 (de) | 1998-10-15 | 2000-04-20 | Brahms Diagnostica Gmbh | Verfahren und Substanzen für die Diagnose und Therapie von Sepsis und sepsisähnlichen systemischen Infektionen |
| EP1111050B1 (fr) * | 1999-12-22 | 2007-03-14 | Dade Behring Marburg GmbH | Solutions de procalcitonine humaine |
| DE10027954A1 (de) | 1999-12-22 | 2001-06-28 | Dade Behring Marburg Gmbh | Humanes Procalcitonin, dessen Herstellung und Verwendung |
| US7713705B2 (en) * | 2002-12-24 | 2010-05-11 | Biosite, Inc. | Markers for differential diagnosis and methods of use thereof |
| EP1628136A1 (fr) * | 2004-08-19 | 2006-02-22 | B.R.A.H.M.S. Aktiengesellschaft | Procédé diagnostic pour des maladies utilisant la copeptin |
| DE102006053442A1 (de) * | 2006-11-12 | 2008-05-15 | Brahms Aktiengesellschaft | Diagnose und Risikostratifizierung von Infektionen und chronischen Erkrankungen der Atemwege und Lunge mittels proVasopressin, insbesondere Copeptin oder Neurophysin II |
| DE102007021443A1 (de) * | 2007-05-08 | 2008-11-13 | Brahms Aktiengesellschaft | Diagnose und Risikostratifizierung mittels NT-proET-1 |
-
2006
- 2006-10-01 DE DE102006046996A patent/DE102006046996A1/de not_active Ceased
-
2007
- 2007-10-01 EP EP07817601.3A patent/EP2084545B1/fr active Active
- 2007-10-01 ES ES07817601.3T patent/ES2455168T3/es active Active
- 2007-10-01 WO PCT/DE2007/001759 patent/WO2008040328A2/fr active Application Filing
- 2007-10-01 US US12/443,897 patent/US8465941B2/en active Active
- 2007-10-01 JP JP2009529533A patent/JP5058263B2/ja active Active
- 2007-10-01 CN CN200780036753.6A patent/CN101553733B/zh active Active
-
2010
- 2010-02-05 HK HK10101319.0A patent/HK1137807A1/xx unknown
-
2012
- 2012-07-02 JP JP2012148614A patent/JP5663531B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US8465941B2 (en) | 2013-06-18 |
| JP5663531B2 (ja) | 2015-02-04 |
| EP2084545B1 (fr) | 2014-02-12 |
| JP2012185187A (ja) | 2012-09-27 |
| EP2084545A2 (fr) | 2009-08-05 |
| ES2455168T3 (es) | 2014-04-14 |
| JP2010506146A (ja) | 2010-02-25 |
| CN101553733A (zh) | 2009-10-07 |
| CN101553733B (zh) | 2014-02-26 |
| JP5058263B2 (ja) | 2012-10-24 |
| US20100047835A1 (en) | 2010-02-25 |
| DE102006046996A1 (de) | 2008-04-03 |
| WO2008040328A3 (fr) | 2008-06-05 |
| WO2008040328A2 (fr) | 2008-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1137807A1 (en) | Diagnosis of infections or inflammatory diseases of the airways and lungs associated with heart failure | |
| PT2170848E (pt) | Derivados da pirazinona e sua utilização no tratamento de doenças pulmonares | |
| IL222542A (en) | Use of a compound to prepare a drug to inhibit and diagnose proteinuria in the lung | |
| PL2379088T3 (pl) | Leczenie płuca oraz chorób i zaburzeń płucnych | |
| EP2005168A4 (fr) | Procedes et compositions destines au diagnostic de maladies de l'aorte | |
| EP2019965A4 (fr) | Procedes de diagnostic d'une maladie pulmonaire et/ou cardiovasculaire | |
| FR2921499B1 (fr) | Structure orientable de type catheter ou endoscope | |
| IL204723A0 (en) | Combination comprising purine derivatives and other compounds and the use thereof for the treatment of inflammatory and obstructive airway diseases | |
| IL186749A0 (en) | Dihydrothienopyrimidines for the treatment of inflammatory diseases | |
| BRPI0918342A2 (pt) | aparelho de respiração configurado para auxiliar as vias respiratórias de um indivíduo enquanto o indivíduo respira | |
| IL190338A0 (en) | Biphenyloxyacetic acid derivatives for the treatment of respiratory disease | |
| IL166183A0 (en) | Novel diagnostic and imaging techniques of the gi tract | |
| IL193604A (en) | Use of human anti-22 @ il antibodies for @ preparation | |
| EP2440196A4 (fr) | Traitement d'une maladie pulmonaire obstructive chronique par administration de bêta 2 agoniste nébulisé ou d'une combinaison de bêta 2 agoniste nébulisé et d'anticholinergique | |
| EP2164505A4 (fr) | Traitement d'une maladie chronique des poumons | |
| EP2021016A4 (fr) | Antagonistes de cxcl13 et leur utilisation pour le traitement de maladies inflammatoires | |
| NO20054180D0 (no) | Behandling av bakterielle sykdommer i andedrettsorganene ved lokal tilforsel av fluorkinoloner | |
| ZA201002989B (en) | New antibodies specific of the beta-amyloid and their uses as diagnostic agents or drugs | |
| EP1962869A4 (fr) | Traitement de maladies respiratoires | |
| EP2086646A4 (fr) | Cathéter nasal à passages d'air internes et externes | |
| HK1166016A1 (en) | The use of glucan on upper respiratory tract infection symptoms and psychological well being | |
| BRPI0721783A2 (pt) | "meio multicamada carregado e respirador" | |
| EP2555785B8 (fr) | Utilisation de streptococcus salivarius pour le traitement d'infections de la voie respiratoire | |
| PL2251016T3 (pl) | Miejscowe zastosowanie kwasu hialuronowego o działaniu filmotwórczym do leczenia i profilaktyki schorzeń dróg oddechowych | |
| EP2170932A4 (fr) | Compositions et leurs utilisations dans le traitement du syndrome de détresse respiratoire aigu (ards) et de troubles cliniques associés à celui-ci |